TEAD2 and cancer: Based on its negative regulation of cell death, its emerging oncogenic role in mediating transcription of genes involved in cancer-cell proliferation, cell migration, and angiogenesis [10], as well as its key role in the Hippo signaling pathway, TEAD2 was selected for further studies of molecular mechanisms of resistance to trastuzumab.